arrow_back Back to App

Extension of support for combating tick-borne diseases

This bill extends funding and programs aimed at combating tick-borne diseases, such as Lyme disease. This means continued research, prevention efforts, and support for local health departments, potentially improving citizens' health security regarding these illnesses.
Key points
Programs for combating tick-borne diseases, including the national strategy and regional centers, will be extended until 2030.
Support for local health departments in identifying, reporting, preventing, and responding to these diseases will be extended until 2030.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4348
Sponsor: Rep. Smith, Christopher H. [R-NJ-4]
Process start date: 2025-07-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To reauthorize the Kay Hagan Tick Act, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4348.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-10.

What are the main provisions?

Key points include:

  • Programs for combating tick-borne diseases, including the national strategy and regional centers, will be extended until 2030.
  • Support for local health departments in identifying, reporting, preventing, and responding to these diseases will be extended until 2030.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Smith, Christopher H. [R-NJ-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health